We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$27.8B
AUM Growth
+$2.54B
Cap. Flow
+$477M
Cap. Flow %
1.71%
Top 10 Hldgs %
17.19%
Holding
2,397
New
92
Increased
1,264
Reduced
960
Closed
73

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$37.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$35.5M
3
VZ icon
Verizon
VZ
+$26.4M
4
TFC icon
Truist Financial
TFC
+$26.1M
5
CTXS
Citrix Systems Inc
CTXS
+$18.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$53.1M
2
STI
SunTrust Banks, Inc.
STI
+$25.3M
3
CHL
China Mobile Limited
CHL
+$16.9M
4
CUK
Carnival PLC
CUK
+$15M
5
WBK
Westpac Banking Corporation
WBK
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Financials 17.05%
3 Healthcare 13.54%
4 Consumer Discretionary 9.51%
5 Communication Services 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRCX icon
176
Lam Research
LRCX
$342B
$35.8M 0.13%
1,225,430
+50,720
+4% +$1.35M
AON icon
177
Aon
AON
$64.2B
$35.8M 0.13%
171,849
+2,720
+2% +$539K
DG icon
178
Dollar General
DG
$27.5B
$35.5M 0.13%
227,370
+4,684
+2% +$743K
IX icon
179
ORIX
IX
$41.7B
$35.4M 0.13%
2,124,725
+5,215
+0.2% +$83.7K
BP icon
180
BP
BP
$118B
$35.4M 0.13%
937,009
+24,109
+3% +$915K
BSX icon
181
Boston Scientific
BSX
$65.3B
$35.1M 0.13%
776,804
-7,745
-1% -$324K
NEM icon
182
Newmont
NEM
$130B
$35M 0.13%
804,769
+225,890
+39% +$8.83M
MRSH
183
Marsh
MRSH
$84.4B
$34.8M 0.12%
311,937
+7,253
+2% +$758K
ROP icon
184
Roper Technologies
ROP
$39B
$34.4M 0.12%
97,165
-1,931
-2% -$667K
VLO icon
185
Valero Energy
VLO
$110B
$34.2M 0.12%
365,054
+6,238
+2% +$590K
MAR icon
186
Marriott International
MAR
$87.3B
$34.1M 0.12%
225,158
+5,095
+2% +$683K
STLA icon
187
Stellantis
STLA
$15.3B
$33.9M 0.12%
2,304,394
-617,355
-21% -$8.93M
KB icon
188
KB Financial Group
KB
$46.3B
$33.8M 0.12%
818,100
+103,831
+15% +$3.97M
SRE icon
189
Sempra
SRE
$54.5B
$33.8M 0.12%
446,250
+30,050
+7% +$2.2M
ICE icon
190
Intercontinental Exchange
ICE
$88.4B
$33.6M 0.12%
362,553
+10,295
+3% +$955K
HMC icon
191
Honda
HMC
$42.2B
$33.5M 0.12%
1,184,342
+15,183
+1% +$423K
CL icon
192
Colgate-Palmolive
CL
$69.2B
$33.4M 0.12%
485,345
-25,611
-5% -$1.75M
ROST icon
193
Ross Stores
ROST
$73.7B
$33.3M 0.12%
286,173
+3,934
+1% +$443K
MSI icon
194
Motorola Solutions
MSI
$77.1B
$33.2M 0.12%
205,993
+1,503
+0.7% +$247K
SCHW
195
Charles Schwab
SCHW
$185B
$32.5M 0.12%
682,836
+10,152
+2% +$448K
RELX icon
196
RELX
RELX
$62.2B
$31.6M 0.11%
1,250,871
+21,403
+2% +$512K
VRTX icon
197
Vertex Pharmaceuticals
VRTX
$132B
$31.5M 0.11%
143,696
+5,705
+4% +$1.15M
BAP icon
198
Credicorp
BAP
$29.9B
$31.4M 0.11%
147,442
-1,267
-0.9% -$265K
YUM icon
199
Yum! Brands
YUM
$39.9B
$31.3M 0.11%
310,395
-15,656
-5% -$1.62M
CCI icon
200
Crown Castle
CCI
$31.6B
$30.9M 0.11%
217,548
+4,755
+2% +$649K
6 7
8
9 10

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q4 2019 Portfolio in Review

As of Q4 2019, Aperio Group held 2,397 positions worth $27.8B, up 10% from $25.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Aperio Group's Q4 2019 filing shows 92 new, 1,264 increased, 960 reduced and 73 closed positions. Its largest new stake was Cerence: 67,887 shares worth $1.54M. The largest sale was Celgene Corp, an estimated $53.1M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2019 buy was Cerence: 67,887 shares worth $1.54M.
  • Aperio Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $37.3M increase.
  • Aperio Group's biggest Q4 2019 reduction was China Mobile Limited, cutting an estimated $16.9M.
  • Aperio Group fully exited Celgene Corp in Q4 2019, selling an estimated $53.1M.
  • Aperio Group's ten largest holdings make up 17% of its $27.8B portfolio in Q4 2019.
  • Aperio Group opened 92 new positions and closed 73 in Q4 2019.
  • Aperio Group's portfolio value rose 10% quarter-over-quarter to $27.8B.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.